This podcast segment features the Q&A from DistillerSR’s November 17, 2022 webinar and features a panel of experts, including Chris Waters-Banker, Maria Arregui, Rajshree Pandey, Lee-Anne Bourke, and Patti Peeples as they answer questions on what Health Technology Assessment (HTA)… Continue Reading
Standard cost-effectiveness analysis (CEA) does not provide the information about distributional equity impacts that decision makers need to reduce unjust differences in health by socioeconomic status, ethnicity and other aspects of social disadvantage. Continue Reading
Recently, there have been encouraging commitments around the world to manufacture coronavirus disease 2019 (COVID-19) vaccines in anticipation of results from clinical studies. Continue Reading
Written By: Americans spend more on prescription drugs than anyone else in the world. In a move to address this, CVS Caremark announced in August that it would allow self-funded insurers to exclude from their plan any drug launched at… Continue Reading
Hardly a day goes by without a new article being published in the mainstream press or a medical journal discussing drug pricing. The cost of drugs is a hot potato topic at medical meetings, pharma conference rooms, government hearings, and… Continue Reading
